The Lincolnian Online logo

The Latest Headlines at The Lincolnian Online

Image about National CineMedia (NASDAQ:NCMI) Lifted to Hold at StockNews.com

National CineMedia (NASDAQ:NCMI) Lifted to Hold at StockNews.com

StockNews.com upgraded shares of National CineMedia (NASDAQ:NCMI – Free Report) from a sell rating to a hold rating in a research note released on Tuesday. NCMI has been the subject of a number of other reports. Benchmark reissued... More of this article »
Image about Hollysys Automation Technologies (NASDAQ:HOLI) Earns Buy Rating from Analysts at StockNews.com

Hollysys Automation Technologies (NASDAQ:HOLI) Earns Buy Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Hollysys Automation Technologies (NASDAQ:HOLI – Free Report) in a research note issued to investors on Tuesday morning. The brokerage issued a buy rating on the industrial products company’s... More of this article »
Image about The Dixie Group (NASDAQ:DXYN) Earns Hold Rating from Analysts at StockNews.com

The Dixie Group (NASDAQ:DXYN) Earns Hold Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of The Dixie Group (NASDAQ:DXYN – Free Report) in a report published on Tuesday morning. The brokerage issued a hold rating on the textile maker’s stock. The Dixie Group Trading Down... More of this article »
Image about Marchex (NASDAQ:MCHX) Research Coverage Started at StockNews.com

Marchex (NASDAQ:MCHX) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Marchex (NASDAQ:MCHX – Free Report) in a report published on Tuesday. The brokerage issued a hold rating on the technology company’s stock. Marchex Price Performance Shares of... More of this article »
Image about StockNews.com Begins Coverage on Genocea Biosciences (NASDAQ:GNCA)

StockNews.com Begins Coverage on Genocea Biosciences (NASDAQ:GNCA)

StockNews.com initiated coverage on shares of Genocea Biosciences (NASDAQ:GNCA – Free Report) in a report released on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Genocea Biosciences... More of this article »
Image about Horace Mann Educators (NYSE:HMN) Stock Rating Lowered by StockNews.com

Horace Mann Educators (NYSE:HMN) Stock Rating Lowered by StockNews.com

StockNews.com downgraded shares of Horace Mann Educators (NYSE:HMN – Free Report) from a buy rating to a hold rating in a report issued on Tuesday. HMN has been the subject of a number of other reports. TheStreet raised shares... More of this article »
Image about StockNews.com Begins Coverage on Macy’s (NYSE:M)

StockNews.com Begins Coverage on Macy’s (NYSE:M)

StockNews.com began coverage on shares of Macy’s (NYSE:M – Free Report) in a report issued on Tuesday morning. The brokerage issued a hold rating on the stock. Several other brokerages also recently weighed in on M. TD... More of this article »
Image about Masonite International (NYSE:DOOR) Earns Hold Rating from Analysts at StockNews.com

Masonite International (NYSE:DOOR) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Masonite International (NYSE:DOOR – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock. Several other brokerages... More of this article »
Image about Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) Price Target at $74.46

Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) Price Target at $74.46

Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twelve analysts that are currently covering the firm, MarketBeat Ratings reports.... More of this article »
Image about Brokerages Set Celestica Inc. (NYSE:CLS) PT at $33.88

Brokerages Set Celestica Inc. (NYSE:CLS) PT at $33.88

Celestica Inc. (NYSE:CLS – Get Free Report) (TSE:CLS) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are presently covering the company, MarketBeat.com reports. One investment analyst... More of this article »
Image about Fennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Adrian J. Haigh Buys 22,222 Shares

Fennec Pharmaceuticals Inc. (TSE:FRX) Senior Officer Adrian J. Haigh Buys 22,222 Shares

Fennec Pharmaceuticals Inc. (TSE:FRX – Get Free Report) Senior Officer Adrian J. Haigh bought 22,222 shares of the stock in a transaction on Monday, April 15th. The shares were acquired at an average cost of C$2.31 per share,... More of this article »
Image about Insider Buying: Haivision Systems Inc. (TSE:HAI) Director Purchases 8,259 Shares of Stock

Insider Buying: Haivision Systems Inc. (TSE:HAI) Director Purchases 8,259 Shares of Stock

Haivision Systems Inc. (TSE:HAI – Get Free Report) Director Miroslav Wicha bought 8,259 shares of Haivision Systems stock in a transaction dated Tuesday, April 16th. The stock was acquired at an average price of C$4.63 per share,... More of this article »
Image about Sandstorm Gold Ltd. (TSE:SSL) Director Purchases C$199,376.00 in Stock

Sandstorm Gold Ltd. (TSE:SSL) Director Purchases C$199,376.00 in Stock

Sandstorm Gold Ltd. (TSE:SSL – Get Free Report) Director Nolan Allan Watson bought 27,200 shares of the business’s stock in a transaction on Monday, April 15th. The stock was purchased at an average cost of C$7.33 per share,... More of this article »
Image about Keefe, Bruyette & Woods Raises M&T Bank (NYSE:MTB) Price Target to $170.00

Keefe, Bruyette & Woods Raises M&T Bank (NYSE:MTB) Price Target to $170.00

M&T Bank (NYSE:MTB – Free Report) had its target price increased by Keefe, Bruyette & Woods from $162.00 to $170.00 in a research note released on Tuesday morning, Benzinga reports. They currently have a market perform... More of this article »
Image about Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are presently covering the stock, MarketBeat Ratings reports.... More of this article »